模型引导的儿童骨肉瘤甲氨蝶呤相关急性肾损伤早期预测:多中心药代动力学研究
本研究基于阿根廷、智利、西班牙和美国多中心248例儿童、青少年及年轻成人骨肉瘤患者的1809个高剂量甲氨蝶呤疗程真实世界数据,建立群体药代动力学模型,发现α处置半衰期是预测中重度急性肾损伤的最准确早期指标(AUC-ROC 0.956),并探索了早期采样策略。
要点
- α处置半衰期可早期预测中重度急性肾损伤,阈值3.4小时,灵敏度0.94,特异度0.96。
- 两点早期采样策略(C4和C8-11)可精确估计α处置半衰期。
- 该模型有助于在输注结束后11小时内识别甲氨蝶呤清除受损,指导支持治疗。
核心结论
- 基于模型指标的α处置半衰期可在输注结束后11小时内早期识别甲氨蝶呤清除受损,为儿童骨肉瘤患者的模型引导精准给药提供实用工具。
研究设计与样本
- 多中心研究纳入阿根廷、智利、西班牙和美国的248例儿童、青少年及年轻成人骨肉瘤患者,共1809个高剂量甲氨蝶呤疗程,使用Monolix建立群体药代动力学模型。
主要发现
- 二室群体药代动力学模型可充分描述输注开始后48小时内的数据,时变血清肌酐被纳入为甲氨蝶呤清除率的关键协变量。
- α处置半衰期是预测中重度急性肾损伤最准确的早期指标,AUC-ROC为0.956(95%CI 0.914-0.998),阈值3.4小时(95%CI 2.7-3.7),灵敏度0.94(95%CI 0.81-1.0),特异度0.96(95%CI 0.73-0.99)。
- 两点早期采样策略(C4和C8-11)可精确估计α处置半衰期。
关键数值与推荐
- α处置半衰期预测中重度急性肾损伤的阈值为3.4小时(95%CI 2.7-3.7)。
- 早期采样策略采用C4和C8-11两个时间点。
临床怎么用
- 可利用α处置半衰期在输注结束后11小时内早期识别甲氨蝶呤清除受损,指导支持治疗和模型引导精准给药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: High-dose methotrexate is central to pediatric osteosarcoma treatment, but delayed elimination increases the risk of acute kidney injury, compromising treatment intensity. Current therapeutic drug monitoring often identifies toxicity too late for intervention. This study aimed to develop a population pharmacokinetic model using real-world data to identify early predictors of methotrexate-associated acute kidney injury. METHODS: We conducted a multicenter study including 248 pediatric, adolescent, and young adult patients with osteosarcoma (1809 high-dose methotrexate courses) from referral centers in Argentina, Chile, Spain, and the USA. A population pharmacokinetic model was developed using Monolix. Early predictors of acute kidney injury were assessed using receiver operating characteristic curve analysis, and optimal sampling times earlier than those currently used in the clinics for rescue measures were explored through simulation. RESULTS: A two-compartment population pharmacokinetic model adequately described the data up to 48 h after the start of infusion. Time-varying serum creatinine was included as a key covariate for methotrexate clearance. The alpha disposition half-life was the most accurate early predictor of moderate-to-severe acute kidney injury (area under the curve-receiver operating characteristic: 0.956 (95% confidence interval (CI) 0.914-0.998); threshold: 3.4 h (95% confidence interval 2.7-3.7), sensitivity: 0.94 [95% CI 0.81-1.0], and specificity: 0.96 [95% CI 0.73-0.99]). A two-point early sampling strategy (C4 and C8-11) precisely estimated alpha disposition half-life. CONCLUSIONS: Early identification of impaired methotrexate clearance is feasible using model-based metrics available within the first 11 h after the end of infusion by means of the alpha disposition half-life. This approach may guide supportive care offering a practical tool for model-informed precision dosing in pediatric patients with osteosarcoma.
引用
- Rega P, Vallespin JM, Aldaz A, et al. A Model-Informed Early Prediction of Methotrexate-Induced Acute Kidney Injury in Pediatric Patients with Osteosarcoma Using Real-World Data: A Multi-center Pharmacokinetic Study. Clin Pharmacokinet. 2026. PMID: 42243443. doi:10.1007/s40262-026-01658-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。